SynthesisJournal of ethnobiology and ethnomedicine2026
A systematic review of ethnobotanical study in Indonesia: diversity and cultural patterns of medicinal plant use.
Synthesis in Journal of ethnobiology and ethnomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Multitarget Pharmacological Mechanisms and Safety Profiles of Six Ethnobotanically Prioritized Indonesian Medicinal Plants for Cardiometabolic Disorders: A Systematic Review.Drug design, development and therapy · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndonesia holds immense biocultural diversity, yet ethnobotanical data remain fragmented. This systematic review synthesizes medicinal plant use across the archipelago to identify cross-cultural patterns, define a core ethnomedicinal flora, and critically appraise methodological rigor.
methodsIn adherence to PRISMA 2020 guidelines, primary field studies were retrieved from PubMed, Scopus, and GARUDA. Scientific names were harmonized using Plants of the World Online (POWO), and therapeutic indications were mapped to ICPC-2 disease categories. Methodological quality was assessed using a modified JBI checklist.
resultsA total of 91 studies were analyzed, yielding 3,202 use-reports for 791 medicinal plant species. Documentation was found to be geographically skewed toward Sumatra and Java, leaving Eastern Indonesia significantly underrepresented. A shared medicinal flora of 239 species was identified across multiple ethnic groups, dominated by versatile plants such as Zingiber officinale and Orthosiphon aristatus. High consensus was observed for acute conditions (e.g., Psidium guajava for diarrhoea), whereas chronic diseases like hypertension demonstrated diverse plant utilization. Quality assessment revealed that 89% of the included studies lacked explicit ethics reporting, and 32% relied on secondary identification without voucher specimens.
conclusionsA culturally salient core of medicinal plants was identified alongside unique regional adaptations. However, the existing literature is compromised by weak taxonomic validation and non-standardized reporting. Future research priorities must include the documentation of neglected regions and the enforcement of rigorous, voucher-based methodologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.